PREVDUO
NDC 42023-269, neostigmine methylsulfate and glycopyrrolate, injection, from Endo USA.
- Product NDC
- 42023-269
- Status
- Listed
- Labeler
- Endo USA
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216903
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42023-269 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE1 mg/mL
- GLYCOPYRROLATE.2 mg/mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42023-269-05 | 42023026905 | 5 SYRINGE, PLASTIC in 1 CARTON (42023-269-05) / 3 mL in 1 SYRINGE, PLASTIC (42023-269-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dd8ad38f-247b-4948-a13c-8f3a4921b4f1
Use it
Look up 42023-269 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42023-269 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42023-269. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.